Deschutes Portfolio Strategy »

Ascendis Pharma AS shares owned by Deschutes Portfolio Strategy

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Deschutes Portfolio Strategy from 13F filings

Historical chart of Deschutes Portfolio Strategy investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Deschutes Portfolio Strategy consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Deschutes Portfolio Strategy

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.5M 28k 266.72

More positions owned by Deschutes Portfolio Strategy

Apple (AAPL)
Ishares Tr Core Div Grwth (DGRO)
Lam Research Corp Com New (LRCX)
Pimco CA Municipal Income Fund (PCQ)
Ascendis Pharma A/s Ord Shs (ASND)
Taiwan Fund (TWN)
Fs Credit Opportunities Corp Common Stock (FSCO)
Korea Com New (KF)
Xai Floating Rate & Alter In Com Shs Benf Int (XFLT)
Fs Specialty Lending Com Sh Ben Int (FSSL)
Microsoft Corporation (MSFT)
Nexpoint Diversified Rel Et Com New (NXDT)
Alphabet Cap Stk Cl A (GOOGL)
Highland Opps & Income Highland Income (HFRO)
Pimco NY Muni Income Fund II (PNI)

View all positions for Deschutes Portfolio Strategy

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS